Summary. Plasma concentrations of ethynyl oestradiol and norethindrone in women were measured by radioimmunoassays after oral administration of 50 pg and 1000 pg respectively. The maximum values were obtained 1 h after administration. The calculated half-life was 6\ m=1/ 2\ h for ethynyl oestradiol and 7 h for norethindrone. At most 2\ p=n-\ 3% of the administered dose was present in the plasma at 1 h and had decreased to about 0\ m=. \ 5 % by 24 h.
Introduction
The synthetic steroids norethindrone (17a-ethynyl-17ß-hydroxy-4-oestren-3-one) and ethynyl oestradiol (17a-ethynyl-l,3,5(10)-oestratiene-3,17ß-diol) are the most widely used components of hormonal contraceptives. Studies on the metabolism of these compounds in women have demon¬ strated that the ethynyl group in norethindrone remains intact (Kamyab, Fotherby & Littleton, 1967 ;  Kamyab, Fotherby & Klopper, 1968 ; Fotherby, 1974) , but that the ring A is transformed into several reduced products, i.e. 17rz-ethynyl-17ß-hydroxy-5a-oestran-3-one and 17ct-ethynyl-5a-oestrane-3ß,17ß-diol (Murata, 1968) , 17o>ethynyl-5a-oestrane-3a,17ß-diol and 17a-ethynyl-5ß-oestrane3a,17ß-diol (Gerhards, Hecker, Hitze, Nieuweboer & Bellmann, 1971 ; Stillwell, Horning, Horning, Stillwell & Zlatkis, 1972) . Following oral administration of [4-14C] ethynyl oestradiol to women, 30-34 % of the dose is excreted in the urine and 22 % in the faeces ; most of the radioactivity of the material, obtained as free fractions or after hydrolysis, was found to be unchanged (Reed, Fotherby, Steele&Addison,1972) .
The present study was an investigation of the plasma concentrations of unmetabolized norethin¬ drone and ethynyl oestradiol at different times after oral administration of these steroids to women. A preliminary account has appeared elsewhere (Kind, Pasqualini & Hill, 1975 (Bliss, 1967; Bruning & Kintz, 1968) . Biological half-life was estimated by planimetrie determination ofthe area under the curve for each hormone.
Results
The progestagenic component Two of the preparations of norethindrone tested (Norinyl-1 and Mead Johnson 1-50) con¬ tained the free alcohol whereas the third (Norlestrin-1) contained the corresponding 17-acetate at the same dose level (1 mg). The 17-acetate cleaves readily following oral administration with the for¬ mation of a free alcohol (Fotherby, 1974) . The present results support these findings: in this study we found no differences in plasma levels between Norinyl-1 and Norlestrin-1 ( (Table I ). The mean plasma levels changed significantly over the 24-h period (F= 8-06, d .f. = 5-25, < 0005). As was the case with norethindrone, the highest absolute value occurred at 1 h. The data show that a high level of ethynyl oestradiol is maintained for at least 3 h and a decrease occurs between 3 and 5 h to a level which is maintained for at least 24 h. The biological half-life for ethynyl oestradiol was estimated to be about 7 h. . The value at 24 h decreased to about 0-5 %.
The estimation of 7 h for the biological half-life of ethynyl oestradiol is in good agreement with the data reported by Warren & Fotherby (1973) , who based their calculation on the material obtained by extracting plasma with ether and assaying ethynyl oestradiol by a competitive protein-binding method using a rabbit uterine cytosol preparation (Korenman, Perrin & McCallum, 1969) . These authors also found a maximum value for ether-extractable material 1 h after ingestion, a finding similar to that in the present paper. However, Warren & Fotherby calculated that the half-life 8 h after administration was 48 h ; this difference could be explained by the existence of at least two components, one for the unmetabolized ethynyl oestradiol of 7-8 h and the other, much longer, for the metabolites. The half-life of 6£ h which we found for norethindrone is also in agreement with the values of 3 and 5 h found by Warren & Fotherby (1974) after oral administration of 1 mg nor¬ ethindrone and using a radioimmunoassay with 125I-labelled norethindrone.
